MG
PLSE icon

Michael Gelband’s Pulse Biosciences PLSE Stock Holding History

Michael Gelband’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,122
Closed -$345K – 1981
2025
Q4 		$345K Buy
25,122
+3,258
+15% +$50.8K ﹤0.01% 1272
2025
Q3 		$387K Buy
+21,864
New +$346K ﹤0.01% 1244

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Michael Gelband's PLSE Position: Q1 2026 in Review

Michael Gelband sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 25,122 shares — an estimated $345K sold.

Michael Gelband first reported a position in PLSE in Q3 2025 and held it in 2 quarters. The position peaked at $387K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Michael Gelband reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 25,122 Pulse Biosciences shares in Q1 2026, an estimated $345K.
  • Michael Gelband first reported a position in Pulse Biosciences in Q3 2025 and held it in 2 quarters.
  • Michael Gelband's Pulse Biosciences position peaked at $387K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.